Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer
by Novoplansky, Ofra (Author)
, Shnerb, Avital B. (Author)
, Marripati, Divyasree (Author)
, Jagadeeshan, Sankar (Author)
, Abu Shareb, Raghda (Author)
, Conde-Lopez, Cristina (Author)
, Zorea, Jonathan (Author)
, Prasad, Manu (Author)
, Ben Lulu, Talal (Author)
, Yegodayev, Ksenia M. (Author)
, Benafsha, Chen (Author)
, Li, Yushi (Author)
, Kong, Dexin (Author)
, Kuo, Fengshen (Author)
, Morris, Luc G. T. (Author)
, Kurth, Ina (Author)
, Heß, Jochen (Author)
, Elkabets, Moshe (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource